1 To evaluate the effect and toxicity of ifosfamide (IFO) combined chemotherapy in recurrent or drug resistant malignant gynecologic cancer.

2 Ifosfamide should be monitored yearly for evidence of Fanconi syndrome, a type of kidney problem.

3 Procarbazine, nitrogen mustard, and ifosfamide, which can increase risk for myelodysplastic syndromes and acute myelogenous leukemia.

4 Objective To summarized the experience in nursing of 42 patients suffered from malignant tumors in advanced stage and conducted chemotherapy including Ifosfamide.

5 Purpose:To investigate the treatment effect and toxicity of regimen containing ifosfamide (IFO) and etoposide (VP16) on relapse ovarian carcinoma.

6 Objectives:To investigate the treatment effect and toxicity of regimen contained ifosfamide (IFO) and carboplatinum (CBP) and pingyangmycinum (PYM) on relapse cervical cancer.

7 Objective To compare the therapeutic effects of Palitaxel and Ifosfamide for malignant gynecological tumors.

8 Objective To evaluate the therapeutic effect and side effects of combined chemotherapy with home made Ifosfamide(IFO) in the retreatment of advanced cancers.

9 Objective To evaluate the clinical efficacy and toxicity of ifosfamide (IFO) combination chemotherapy in patients with advanced gynecologic malignancies.

10 Objective To evaluate therapeutic effects and toxicity of advanced non-small cell lung cancer (NSCLC)treated by combining chemotherapy on ifosfamide(IFO)and vinorelbine(NVB).